William A. Curran
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/27077_wcurran_0.jpg?itok=AAa9MU_H)
Filters
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Novo Holdings investment in Availity
We advised Availity on the investment
Elliott Opportunity II $609.5 million IPO
We advised Elliott Opportunity II Corp., a SPAC, on its IPO and NYSE listing
XP $750 million notes offering
We advised XP on its Rule 144A / Regulation S offering of senior unsecured notes
StoneCo $500 million notes offering
We advised StoneCo on its Rule 144A / Regulation S offering of senior notes
Lydall $1.3 billion acquisition by Unifrax
We are advising Lydall on the transaction
Raven Industries $2.1 billion acquisition by CNH Industrial
We are advising Raven Industries on the transaction
Mitsubishi HC Capital acquisition of CAI International
We are advising Mitsubishi HC Capital on the acquisition
Nubank $750 million Series G-1 financing
We advised Nubank on its Series G-1 financing
Mathys sale to DJO
We are advising the Mathys family on the sale